Erratum: Long-term outcomes for patients with limited stage follicular lymphoma
β Scribed by Belinda A. Campbell; Nick Voss; Ryan Woods; Randy D. Gascoyne; James Morris; Tom Pickles; Joseph M. Connors; Kerry J. Savage
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 50 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The management of patients with follicular lymphoma is controversial, particularly in those with follicular small cleaved cell (FSCC) or nodular poorly differentiated lymphoma (NPDL). Some advocate no treatment until symptoms arise, while others prefer to treat with intensive combination regimens an
Background. Follicular lymphoma is a clearly defined type of malignant lymphoma. The many treatment approaches reported in the literature attest to the lack of agreement on its best management. The treatment experiences of patients with Stage I or I1 follicular lymphoma who were at risk for at least
## Abstract Limited stage Hodgkin lymphoma (HL) refers to patients with stage IA or IIA disease in the absence of any bulky mass or unfavourable prognostic factors. In this group, the longβterm disease control with treatment can be expected in more than 90%, and management has now been directed to